Mon May 5, 7:02 PM ET
The University of Helsinki research, published online in Cancer Cell, reveals that PROX1, a protein that controls formation of normal organs in embryos, is produced in excess during the early stages of cancer development. PROX1 even encourages tumor cell growth without additional signals from surrounding normal tissues.
The removal of PROX1 from cancer cells appears to reverse their malignant behavior, suggesting that future research may focus on the protein's use in colon cancer therapies.
Men and women face a lifetime risk of nearly 6 percent for the development of invasive colorectal cancer, making it one of the most common malignancies in the Western world. Past epidemiologic studies have cited obesity and several dietary factors -- including fat, red meat and a lack of vegetables and fiber -- as increasing the risk of the disease.
More information
The National Cancer Institute has more about colorectal cancer screening.
( What's this? )
Copyright © 2008 HealthDay.
All rights reserved.
The information contained above is intended
for general reference purposes only. It is not a substitute for professional
medical advice or a medical exam. Always seek the advice of your physician
or other qualified health professional before starting any new treatment.
Medical information changes rapidly and while Yahoo and its content providers
make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated
by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.